Literature DB >> 3707314

Intellectual and cognitive function in adults with myotonic muscular dystrophy.

M M Portwood, J J Wicks, J S Lieberman, M J Duveneck.   

Abstract

Intellectual and cognitive function was studied in 43 patients (21 men and 22 women) with myotonic muscular dystrophy (MMD). The inheritance distribution was 18 paternal, 10 maternal, and 15 unknown. All patients received the Wechsler Adult Intelligence Scale-Revised, the Wechsler Memory Scale, the Halstead-Reitan Neuropsychological Test Battery, and the Aphasia Screening Test. Significantly lower scores (p less than 0.05) were found on all intellectual and cognitive impairment tests in both men and women of the maternal inheritance MMD subgroup, compared with the paternal inheritance MMD subgroup and with the normative data. Scores for patients with paternally inherited disease did not differ significantly from normative data for verbal, performance, or full scale intelligence quotients and memory quotients. There were no significant differences in intellectual and cognitive test scores between men and women for the group as a whole, for the maternal inheritance subgroup, or for the paternal inheritance subgroup. It is suggested that inheritance pattern is a necessary variable in studies investigating intellectual and cognitive function in MMD. Although the reason for the association of lower intellectual and cognitive function in MMD of maternal inheritance is not known, the data presented here may be useful for genetic counseling.

Entities:  

Mesh:

Year:  1986        PMID: 3707314

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  8 in total

1.  Mild myotonic dystrophy is associated with memory impairment in the context of normal general intelligence.

Authors:  J S Rubinsztein; D C Rubinsztein; P J McKenna; S Goodburn; A J Holland
Journal:  J Med Genet       Date:  1997-03       Impact factor: 6.318

2.  Neuropsychological deficits in myotonic muscular dystrophy.

Authors:  P Malloy; S K Mishra; S H Adler
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-11       Impact factor: 10.154

Review 3.  Therapeutics development in myotonic dystrophy type 1.

Authors:  Erin Pennock Foff; Mani S Mahadevan
Journal:  Muscle Nerve       Date:  2011-05-23       Impact factor: 3.217

4.  Fatigue and daytime sleepiness rating scales in myotonic dystrophy: a study of reliability.

Authors:  L Laberge; C Gagnon; S Jean; J Mathieu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-10       Impact factor: 10.154

5.  Genome modification leads to phenotype reversal in human myotonic dystrophy type 1 induced pluripotent stem cell-derived neural stem cells.

Authors:  Guangbin Xia; Yuanzheng Gao; Shouguang Jin; S H Subramony; Naohiro Terada; Laura P W Ranum; Maurice S Swanson; Tetsuo Ashizawa
Journal:  Stem Cells       Date:  2015-06       Impact factor: 6.277

6.  Generation of neural cells from DM1 induced pluripotent stem cells as cellular model for the study of central nervous system neuropathogenesis.

Authors:  Guangbin Xia; Katherine E Santostefano; Marianne Goodwin; Jilin Liu; S H Subramony; Maurice S Swanson; Naohiro Terada; Tetsuo Ashizawa
Journal:  Cell Reprogram       Date:  2013-04       Impact factor: 1.987

Review 7.  Human iPSC Models to Study Orphan Diseases: Muscular Dystrophies.

Authors:  Guangbin Xia; Naohiro Terada; Tetsuo Ashizawa
Journal:  Curr Stem Cell Rep       Date:  2018-10-04

Review 8.  Myotonic dystrophy type 1 accompanied with normal pressure hydrocephalus: a case report and literature review.

Authors:  Junyang Wang; Ming Liu; Wenjie Shang; Zhongqin Chen; Guoping Peng
Journal:  BMC Neurol       Date:  2020-02-12       Impact factor: 2.474

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.